SCHEMBL22155455

SCHEMBL22155455

c1ccc2c(c1)cc(-c1c3ccccc3c(-c3c4ccccc4c(-c4ccc5c(c4)c4ccccc4c4cc6c(cc54)sc4ccc5ccccc5c46)c4ccccc34)c3ccccc13)c1ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.36
NQO2 P16083 2/20 0.35
NQO1 P15559 1/20 0.35
HPRT1 P00492 4/20 0.33
ALDH1A1 P00352 3/20 0.33
HIF1A Q16665 3/20 0.33
CYP1A2 P05177 2/20 0.33
HPGD P15428 2/20 0.33
MAPK1 P28482 2/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
ALOX12 P18054 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 2/20 0.32
CYP1B1 Q16678 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22155539 0.88 CYP1A1 (0.35) SOS1NQO2NQO1HPRT1ALDH1A1
SCHEMBL22155409 0.87 KDM4E (0.33) SOS1NQO2NQO1HPRT1ALDH1A1
SCHEMBL22155049 0.86 NQO2 (0.37) NQO2NQO1HPRT1CYP1B1ALOX5
SCHEMBL22155424 0.85 NQO2 (0.33) SOS1NQO2NQO1ALDH1A1HIF1A
SCHEMBL22218794 0.85 HPRT1 (0.39) SOS1NQO2NQO1HPRT1ALDH1A1
SCHEMBL24282333 0.84 HPRT1 (0.34) NQO2NQO1HPRT1ALDH1A1HIF1A
SCHEMBL22260292 0.83 CYP1A1 (0.35) NQO2NQO1HPRT1CYP1A2CYP2D6
SCHEMBL22217298 0.82 ALDH1A1 (0.39) SOS1NQO2NQO1HPRT1ALDH1A1
SCHEMBL27302257 0.82 ALDH1A1 (0.37) SOS1NQO2NQO1HPRT1ALDH1A1
SCHEMBL27302931 0.81 NQO2 (0.35) SOS1NQO2NQO1HPRT1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11296282-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-04-05 US disclosed
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11296282-B2 Organic compound and organic electroluminescence device using the same SLCO4C1, EML4, SLCO2A1 SOS1 1759/4885NQO2 1965/4885NQO1 951/4885
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME SLCO4C1, EML4, SLCO2A1 SOS1 1759/4885NQO2 1965/4885NQO1 951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.